This company has shut down. The Valens Company is no longer operating — its last tracked round was a Post-IPO Equity in 2022.
Explore the Startup GraveyardThe Valens Company is a biotechnology company focused on extraction and the commercialization of cannabinoid-based consumer products.
The Valens Company has raised $25.8M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2022.
The Valens Company's investors include CIBC, ATB Financial, 2361380 Ontario.
The Valens Company is headquartered in Kelowna, Canada.
The Valens Company is a biotechnology company focused on extraction and the commercialization of cannabinoid-based consumer products.
The Valens Company is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"The Valens Company — Funding & Investors." VCBacked, March 29, 2022, https://www.vcbacked.co/company/the-valens-company. Accessed August 17, 2026.
VCBacked. (2022). The Valens Company — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/the-valens-company
{{cite web |title=The Valens Company — Funding & Investors |url=https://www.vcbacked.co/company/the-valens-company |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated